Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India. (يفتح نافذة جديدة)

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

Source‎: Hemoglobin 2014;38(1):44-8.

مفهرسة‎: PubMed 24144212

DOI‎: 10.3109/03630269.2013.845844

https://www.ncbi.nlm.nih.gov/pubmed/24144212 (يفتح نافذة جديدة)

Hydroxyurea in thalassemia intermedia--a promising therapy. (يفتح نافذة جديدة)

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

Source‎: Ann Hematol 2005;84(7):441-6.

مفهرسة‎: PubMed 15838670

DOI‎: 10.1007/s00277-005-1026-4

https://www.ncbi.nlm.nih.gov/pubmed/15838670 (يفتح نافذة جديدة)

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. (يفتح نافذة جديدة)

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

Source‎: J Clin Pathol 2010;63(2):147-50.

مفهرسة‎: PubMed 20154037

DOI‎: 10.1136/jcp.2009.070391

https://www.ncbi.nlm.nih.gov/pubmed/20154037 (يفتح نافذة جديدة)

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. (يفتح نافذة جديدة)

Karimi M, Borzouee M, Mehrabani A, Cohan N.

Source‎: Eur J Haematol 2009;82(3):213-8.

مفهرسة‎: PubMed 19077048

DOI‎: 10.1111/j.1600-0609.2008.01192.x

https://www.ncbi.nlm.nih.gov/pubmed/19077048 (يفتح نافذة جديدة)

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. (يفتح نافذة جديدة)

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

Source‎: Eur J Haematol 2010;84(1):52-8.

مفهرسة‎: PubMed 19799627

DOI‎: 10.1111/j.1600-0609.2009.01356.x

https://www.ncbi.nlm.nih.gov/pubmed/19799627 (يفتح نافذة جديدة)

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. (يفتح نافذة جديدة)

Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.

Source‎: Blood Cells Mol Dis 2000;26(5):453-66.

مفهرسة‎: PubMed 11112383

DOI‎: 10.1006/bcmd.2000.0328

https://www.ncbi.nlm.nih.gov/pubmed/11112383 (يفتح نافذة جديدة)

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. (يفتح نافذة جديدة)

Perrine SP.

Source‎: Pediatr Ann 2008;37(5):339-46.

مفهرسة‎: PubMed 18543545

https://www.ncbi.nlm.nih.gov/pubmed/18543545 (يفتح نافذة جديدة)

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. (يفتح نافذة جديدة)

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

Source‎: Ann N Y Acad Sci 2005;1054:250-6.

مفهرسة‎: PubMed 16339672

DOI‎: 10.1196/annals.1345.031

https://www.ncbi.nlm.nih.gov/pubmed/16339672 (يفتح نافذة جديدة)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (يفتح نافذة جديدة)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Source‎: Acta Haematol 2004;111(4):189-95.

مفهرسة‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (يفتح نافذة جديدة)

Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. (يفتح نافذة جديدة)

Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G.

Source‎: Blood Purif 2004;22(5):453-60.

مفهرسة‎: PubMed 15359104

DOI‎: 10.1159/000080729

https://www.ncbi.nlm.nih.gov/pubmed/15359104 (يفتح نافذة جديدة)

The role of recombinant human erythropoietin in the treatment of thalassemia. (يفتح نافذة جديدة)

Rachmilewitz EA, Aker M.

Source‎: Ann N Y Acad Sci 1998;850:129-38.

مفهرسة‎: PubMed 9668535

https://www.ncbi.nlm.nih.gov/pubmed/9668535 (يفتح نافذة جديدة)

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. (يفتح نافذة جديدة)

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

Source‎: Br J Haematol 2011;154(2):281-4.

مفهرسة‎: PubMed 21496003

DOI‎: 10.1111/j.1365-2141.2011.08617.x

https://www.ncbi.nlm.nih.gov/pubmed/21496003 (يفتح نافذة جديدة)

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. (يفتح نافذة جديدة)

Thein SL.

Source‎: Blood Rev 2012;26 Suppl 1:S35-9.

مفهرسة‎: PubMed 22631042

DOI‎: 10.1016/S0268-960X(12)70011-5

https://www.ncbi.nlm.nih.gov/pubmed/22631042 (يفتح نافذة جديدة)